BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 26621728)

  • 1. Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.
    Townsend S; Fennell BJ; Apgar JR; Lambert M; McDonnell B; Grant J; Wade J; Franklin E; Foy N; Ní Shúilleabháin D; Fields C; Darmanin-Sheehan A; King A; Paulsen JE; Hickling TP; Tchistiakova L; Cunningham O; Finlay WJ
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15354-9. PubMed ID: 26621728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Significance and Implications of Antibody Numbering and Antigen-Binding Surface/Residue Definition.
    Dondelinger M; Filée P; Sauvage E; Quinting B; Muyldermans S; Galleni M; Vandevenne MS
    Front Immunol; 2018; 9():2278. PubMed ID: 30386328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A germline knowledge based computational approach for determining antibody complementarity determining regions.
    Zhao S; Lu J
    Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
    De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
    J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of human germline genes in a CDR homology-based approach to antibody humanization.
    Hwang WY; Almagro JC; Buss TN; Tan P; Foote J
    Methods; 2005 May; 36(1):35-42. PubMed ID: 15848073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A large human domain antibody library combining heavy and light chain CDR3 diversity.
    Chen W; Zhu Z; Feng Y; Dimitrov DS
    Mol Immunol; 2010 Jan; 47(4):912-21. PubMed ID: 19883941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing.
    Roguska MA; Pedersen JT; Henry AH; Searle SM; Roja CM; Avery B; Hoffee M; Cook S; Lambert JM; Blättler WA; Rees AR; Guild BC
    Protein Eng; 1996 Oct; 9(10):895-904. PubMed ID: 8931129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif.
    Baek DS; Kim YS
    Biochem Biophys Res Commun; 2015 Jul; 463(3):414-20. PubMed ID: 26036575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline-Dependent Antibody Paratope States and Pairing Specific V
    Fernández-Quintero ML; Kroell KB; Bacher LM; Loeffler JR; Quoika PK; Georges G; Bujotzek A; Kettenberger H; Liedl KR
    Front Immunol; 2021; 12():675655. PubMed ID: 34447370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturation of shark single-domain (IgNAR) antibodies: evidence for induced-fit binding.
    Stanfield RL; Dooley H; Verdino P; Flajnik MF; Wilson IA
    J Mol Biol; 2007 Mar; 367(2):358-72. PubMed ID: 17258766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanization of monoclonal antibodies by CDR grafting.
    O'Brien S; Jones T
    Methods Mol Biol; 2003; 207():81-100. PubMed ID: 12412469
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel heavy domain antibody library with functionally optimized complementarity determining regions.
    Mandrup OA; Friis NA; Lykkemark S; Just J; Kristensen P
    PLoS One; 2013; 8(10):e76834. PubMed ID: 24116173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genes coding evolutionary novel anti-carbohydrate antibodies: studies on anti-Gal production in alpha 1,3galactosyltransferase knock out mice.
    Chen ZC; Radic MZ; Galili U
    Mol Immunol; 2000 Jun; 37(8):455-66. PubMed ID: 11090880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.